SEER Seer, Inc. - Class A

We are a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. Our Proteograph is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. We designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers.

$9.54  +1.09 (12.90%)
As of 06/24/2022 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/04/2020
Outstanding shares:  58,396,964
Average volume:  553,826
Market cap:   $493,454,346
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMCWDS6
Valuation   (See tab for details)
PE ratio:   -7.11
PB ratio:   1.22
PS ratio:   50.91
Return on equity:   -16.11%
Net income %:   -808.77%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy